To focus on the launch of berdazimer gel 10.3%, Novan will be restructuring its commercial business and reducing its workforce due to profitability challenges, the company announced in a press release. “We continue to face serious challenges achieving profitability with our commercial assets in the current economic environment, while also endeavoring to extend our cash runway through the